Home / Substances / Hallucinogens
Hallucinogens: Risks, Psychological Dependence and Getting Help
Hallucinogens are a varied group that includes classic psychedelics like LSD, psilocybin, DMT and mescaline, and dissociatives like PCP and DXM. Classic psychedelics carry low risk of physical dependence, but they are not risk-free: bad trips, HPPD (a lasting visual disturbance), and persistent psychosis in vulnerable people are documented and serious. Dissociatives like PCP and DXM behave differently and can produce real compulsive use and dependence. This page separates the categories, explains the risks, and covers how to get help.
Quick answers
Are hallucinogens addictive?
Classic psychedelics like LSD, psilocybin and mescaline carry low risk of physical dependence and withdrawal. Dissociatives like PCP and DXM are different and can produce compulsive use and dependence.
What is a bad trip?
An episode of intense fear, panic, paranoia or disorientation during hallucinogen use. It usually resolves as the drug wears off, but it can be frightening and, rarely, trigger lasting psychological problems.
What is HPPD?
Hallucinogen persisting perception disorder is a condition where visual disturbances from a past hallucinogen experience, such as trails or halos, recur long after the drug has left the body.
Where do I start if I'm concerned about my use?
Call the SAMHSA National Helpline at 1-800-662-4357, free and confidential, or search FindTreatment.gov for programs near you.
What counts as a hallucinogen
The category covers substances with very different mechanisms and risk profiles. The NIDA research topic on hallucinogens and dissociative drugs separates them into two broad groups.
Classic psychedelics
- LSD (acid), a synthetic compound acting on serotonin receptors.
- Psilocybin, the active compound in certain mushrooms.
- DMT, found in some plants and produced synthetically, with a very short duration of action.
- Mescaline, found in peyote and San Pedro cacti.
Dissociatives
- PCP (phencyclidine), which can cause aggression, numbness, and, at high doses, dangerous psychiatric symptoms.
- Ketamine, used medically under supervision but misused recreationally.
- DXM (dextromethorphan), an over-the-counter cough suppressant misused at high doses for dissociative effects.
These two groups behave differently in the body and carry different dependence risks, which is why they are covered separately below.
Psychological risk without classic physical dependence
Classic psychedelics do not produce the same physical withdrawal seen with alcohol, opioids or benzodiazepines. Tolerance builds very quickly with repeated daily use and fades within about a week, which itself limits frequent use.
- Cravings and habitual use can still occur, especially when used to escape difficult emotions or circumstances.
- Repeated use to cope with underlying anxiety, depression or trauma can become a pattern even without physical dependence.
- The absence of a withdrawal syndrome does not mean the absence of risk.
- Judgment and risk-taking are impaired during use, which creates situational danger such as accidents or unsafe environments.
Bad trips, HPPD and persistent psychosis
Most hallucinogen experiences resolve without lasting effects, but a minority of users experience serious and sometimes lasting psychological problems, as documented by NIDA.
| Condition | What it involves | Typical course |
|---|---|---|
| Bad trip | Intense fear, panic, paranoia, or disorientation during use | Usually resolves as the drug wears off, within hours |
| HPPD | Recurring visual disturbances such as trails, halos, or static, without current use | Can persist for weeks, months or longer in a subset of users |
| Persistent psychosis | Ongoing hallucinations, disorganized thinking, or mood disturbance after use | Rare, more likely in people with a personal or family history of psychosis |
| Panic reactions | Acute anxiety severe enough to require support or medical attention | Usually resolves within hours with a calm, safe environment |
People with a personal or family history of schizophrenia, bipolar disorder, or other psychotic conditions face substantially higher risk of triggering a lasting psychiatric episode and are generally advised to avoid these substances entirely.
Clinical psychedelic research versus unsupervised use
Recent research has explored psilocybin and other psychedelics for depression, PTSD and end-of-life anxiety under controlled clinical conditions. These trials differ from typical unsupervised use in several important ways.
- Doses are pharmaceutical-grade and precisely measured, unlike street product of unknown potency.
- Sessions occur with trained clinical staff present throughout, ready to manage a difficult reaction.
- Participants are carefully screened to exclude people at higher risk of psychosis or other serious complications.
- Structured preparation and follow-up sessions are built into the treatment, not the substance alone.
PCP and DXM: a different risk profile
Dissociatives are grouped with hallucinogens but behave more like other drugs of dependence in some respects.
- PCP can cause aggression, numbness to pain, and at high doses, seizures, coma or dangerous psychiatric symptoms.
- Repeated PCP use is linked to cravings and compulsive use patterns similar to other substances of misuse.
- DXM, found in over-the-counter cough and cold products, is misused at doses far above the recommended amount to produce dissociative effects.
- High-dose DXM use can cause rapid heart rate, elevated blood pressure, and impaired coordination, and repeated misuse can lead to a pattern of dependence.
Signs of a developing problem with PCP or DXM
- Using more, or more often, than intended.
- Needing higher amounts for the same effect.
- Continuing despite worsening mood, cognition or relationships.
- Strong cravings, particularly for DXM in specific products.
- Withdrawal-like irritability or low mood between periods of use.
Treatment that works
There is no FDA-approved medication specifically for hallucinogen use disorder. Treatment focuses on the underlying pattern of use and any co-occurring mental health condition.
- Cognitive behavioral therapy, addressing the triggers and beliefs behind repeated use.
- Treatment for co-occurring anxiety, depression or psychosis, often the central issue driving problematic use.
- Motivational interviewing for people still deciding whether to change their pattern of use.
- Medical evaluation for anyone who has experienced HPPD, a bad trip with lasting effects, or a psychotic episode.
- Specialized care for PCP or DXM dependence, which may include closer medical monitoring given the physical risks.
Recovery and getting support
| Situation | What usually helps | Where to look |
|---|---|---|
| Occasional use becoming more frequent | Structured therapy, honest look at what use is masking | Outpatient counseling |
| Lasting visual disturbances (HPPD) | Medical evaluation, sometimes medication for anxiety around symptoms | Primary care or psychiatry referral |
| Psychotic symptoms after use | Prompt psychiatric evaluation, ongoing treatment | Emergency or urgent psychiatric care |
| PCP or DXM dependence | Structured substance use treatment, medical monitoring | Outpatient or residential treatment program |
For those stopping a pattern of frequent use, lingering low mood or unease in the weeks that follow is common and usually temporary; see how long post-acute withdrawal really lasts. Family and friends can help most by staying calm and factual; see how to support a loved one without enabling.
How to get help today
- Call the SAMHSA National Helpline at 1-800-662-4357. Free, confidential, 24 hours a day.
- Search FindTreatment.gov for outpatient counseling and mental health services near you.
- Seek prompt medical care for any psychotic symptoms, severe panic, or lasting visual disturbances after use.
- Get an honest assessment for any personal or family history of psychosis before further use.
- Ask about specialized care if PCP or DXM use has become frequent or compulsive.
Frequently asked questions
Can you get addicted to LSD or psilocybin?
Classic psychedelics like LSD and psilocybin carry low risk of physical dependence and do not produce a classic withdrawal syndrome. Tolerance builds rapidly with repeated use and fades within about a week. Psychological patterns of habitual use can still develop, especially when used to avoid difficult emotions.
What is HPPD and how common is it?
Hallucinogen persisting perception disorder involves recurring visual disturbances, such as trails, halos or static, that continue long after a hallucinogen experience has ended. It is uncommon but documented, and it can persist for weeks, months or longer in affected individuals.
Why do doctors screen so carefully for psychedelic clinical trials?
People with a personal or family history of psychosis or bipolar disorder face a higher risk of triggering a lasting psychiatric episode with hallucinogen use. Clinical trials exclude these individuals and closely monitor participants, which is a major reason trial results do not apply to unsupervised recreational use.
Is PCP more dangerous than classic psychedelics?
Yes, in several respects. PCP can cause aggression, numbness to pain, and at high doses seizures or dangerous psychiatric symptoms. It is also linked to a pattern of compulsive use and dependence that is less typical of classic psychedelics like LSD or psilocybin.
Can you overdose on over-the-counter cough medicine misused for its dissociative effect?
Yes. Taking DXM at doses far above the recommended amount can cause rapid heart rate, elevated blood pressure, impaired coordination, and in serious cases, dangerous medical complications, especially when combined with other ingredients found in combination cold products.
What should I do if someone is having a bad trip?
Move them to a calm, quiet, familiar environment, speak reassuringly, and stay with them until the effects pass. If they show signs of a medical emergency such as chest pain, seizure, or loss of consciousness, call 911.
Are hallucinogens more dangerous for people with mental health conditions?
Yes. People with a personal or family history of psychosis, schizophrenia or bipolar disorder face meaningfully higher risk of triggering a lasting psychiatric episode and are generally advised to avoid these substances.
Is ketamine the same risk category as PCP?
Ketamine is used medically under supervision, including for treatment-resistant depression in monitored clinical settings, but it is also misused recreationally. Misuse outside medical supervision carries dissociative and dependence risks that should be taken seriously.
Do hallucinogens show up on standard drug tests?
Most classic psychedelics are not detected by standard workplace drug panels, though specialized testing can identify them. PCP is included on many standard panels. Testing practices vary, so this should not be relied on as a safety measure.
Where can I find treatment for hallucinogen-related problems?
Start with the SAMHSA National Helpline at 1-800-662-4357 or search FindTreatment.gov for programs and mental health providers in your area who can address both substance use and any co-occurring psychological symptoms.
Talk to someone this week
A doctor or trained helpline counselor can help you choose a safe next step. Support is free and confidential.
Call 1-800-662-4357Sources
- NIDA, Hallucinogens and Dissociative Drugs research topic
- SAMHSA National Helpline, 1-800-662-HELP
- FindTreatment.gov, federal treatment locator
This page is for information only and does not replace advice from a qualified clinician who knows your history. In the United States, call or text 988 for the Suicide and Crisis Lifeline.